<DOC>
	<DOCNO>NCT00569582</DOCNO>
	<brief_summary>Patients receive Corlux ( mifepristone ) daily 24 week . Assessments sign symptom Cushing 's syndrome obtain .</brief_summary>
	<brief_title>A Study Efficacy Safety CORLUX Treatment Endogenous Cushing 's Syndrome</brief_title>
	<detailed_description>Cushing 's syndrome relatively rare disorder cause prolonged exposure high level glucocorticoid hormone cortisol . Cushing 's syndrome may result elevate endogenous exogenous source cortisol . Endogenous Cushing 's syndrome result cortisol overproduction adrenal gland subject protocol . Patients exogenous Cushing 's syndrome , develops side effect chronic administration high dos glucocorticoid , eligible enrollment study . This evaluate safety efficacy mifepristone treatment sign symptom hypercortisolemia patient endogenous Cushing 's syndrome ACTH-dependent adrenal disorder . The study enroll subject investigator determine medical treatment endogenous hypercortisolemia need . Medical treatment may intend treat effect persistent recurrent hypercortisolemia surgery and/or radiation Cushing 's syndrome , bridge period time radiation become effective , surgery feasible .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cushing Syndrome</mesh_term>
	<mesh_term>Mifepristone</mesh_term>
	<criteria>Individuals eligible enrollment study adult male nonpregnant female adult patient : Are least 18 year age Have confirm diagnosis endogenous hypercortisolemia cause ACTH dependent ACTH independent etiology , include 1 . Cushing 's Disease ( recur primary pituitary surgery , fail pituitary surgery , treat radiation therapy pituitary , treatable surgery , exist patient candidate surgery , confirm documentation ACTH immunoreactivity pathological evaluation pituitary tissue previous surgical specimen IPSS centraltoperipheral gradient ( ratio ) &gt; 2 &gt; 3 CRH administration ) . 2 . Ectopic ACTH 3 . Ectopic CRF secretion 4 . Adrenal adenoma 5 . Adrenal carcinoma 6 . Adrenal autonomy Require medical treatment hypercortisolemia Have diabetes mellitus type 2 glucose intolerance AND/OR hypertension *Note : To eligible inclusion subject must document evidence persistent endogenous hypercortisolemia Individuals eligible enrol study : Have de novo Cushing 's disease surgical candidate pituitary surgery . Have acute unstable medical problem , could aggravate mifepristone treatment . Taking medication within 14 day baseline visit ( Day 1 ) ) large first pas metabolism largely mediate CYP3A4 narrow therapeutic margin and/or b ) strong CYP3A4 inhibitor . Female patient reproductive potential , pregnant unable unwilling use medically acceptable , nonhormonal method contraception study . Have receive investigational treatment ( drug , biological agent device ) within 30 day Screening Have history allergic reaction intolerance CORLUX ( mifepristone ) Have nonendogenous source hypercortisolemia factious hypercortisolemia ( exogenous source glucocorticoid , iatrogenic Cushing 's syndrome ) , factious therapeutic use ACTH Have PseudoCushing 's syndrome . Receive PPARgamma agonist drug ( e.g . pioglitazone , rosiglitazone ) within 4 month Baseline ( Day 1 ) . Postmenopausal woman intact uterus experience unexplained vaginal bleeding within 12 month Screening exclude . Have renal failure define serum creatinine â‰¥2.2 mg/dL .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Cushing 's Disease</keyword>
	<keyword>Cushing 's Syndrome</keyword>
	<keyword>Cushings</keyword>
	<keyword>Pituitary</keyword>
	<keyword>ACTH</keyword>
	<keyword>Adrenocorticotropic hormone</keyword>
	<keyword>Ectopic</keyword>
	<keyword>Adrenal adenoma</keyword>
	<keyword>Adrenal carcinoma</keyword>
	<keyword>Adrenal autonomy</keyword>
	<keyword>Cortisol</keyword>
	<keyword>Hypercortisolemia</keyword>
	<keyword>Cushingoid</keyword>
	<keyword>Moon facies</keyword>
	<keyword>Dorsocervical fat</keyword>
	<keyword>Plethora</keyword>
	<keyword>Hirsutism</keyword>
	<keyword>Violaceous stria</keyword>
	<keyword>Hormone</keyword>
	<keyword>Contraceptive</keyword>
	<keyword>Endocrine</keyword>
	<keyword>Cushing Syndrome</keyword>
	<keyword>Ectopic ACTH Secretion</keyword>
</DOC>